Evotec AG announced today a collaboration with Antibiotic Research UK („ANTRUK“) to identify alternative means of treating infections that are resistant to currently available antibiotics. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-awarded-contract-from-antibiotic-research-uk-to-begin-integrated-drug-discovery-collaboration-5376